Northwestern Mutual Wealth Management CO Cue Biopharma, Inc. Transaction History
Northwestern Mutual Wealth Management CO
- $118 Billion
- Q4 2024
A detailed history of Northwestern Mutual Wealth Management CO transactions in Cue Biopharma, Inc. stock. As of the latest transaction made, Northwestern Mutual Wealth Management CO holds 2,500 shares of CUE stock, worth $3,350. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,500
Previous 2,500
-0.0%
Holding current value
$3,350
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding CUE
# of Institutions
57Shares Held
11.9MCall Options Held
22KPut Options Held
1.2K-
Bleichroeder LP New York, NY5MShares$6.7 Million1.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.06MShares$2.76 Million0.0% of portfolio
-
Black Rock Inc. New York, NY757KShares$1.01 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA631KShares$845,9160.0% of portfolio
-
Robertson Stephens Wealth Management, LLC San Francisco, CA479KShares$641,1900.02% of portfolio
About Cue Biopharma, Inc.
- Ticker CUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,381,700
- Market Cap $47.4M
- Description
- Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...